Pyelonephritis nursing: assessment, interventions, and NCLEX review

Pyelonephritis is a bacterial infection of the kidney parenchyma and renal pelvis. It represents the ascent of lower urinary tract infection — most commonly from the bladder — into the upper urinary tract, triggering an inflammatory response that can range from a straightforward outpatient illness to a life-threatening emergency. When untreated or inadequately managed, pyelonephritis progresses to urosepsis, a condition carrying 30–40% mortality.

Nurses encounter pyelonephritis across med-surg, ED, and critical care settings. Understanding the pathophysiology, recognizing the classic presentation, and knowing when to escalate are core competencies — and frequent NCLEX topics. This reference covers everything from admission assessment to urosepsis recognition to patient education.

Quick reference:

Pathophysiology

Pyelonephritis develops when bacteria ascend from the lower urinary tract into the kidneys. The route is: urethra → bladder (cystitis) → ureter → renal pelvis → renal parenchyma. In most cases, the same bacteria causing a bladder infection spread upward — either due to vesicoureteral reflux, urinary obstruction, or factors that allow bacteria to adhere to and migrate along the urothelium.

Once bacteria reach the renal pelvis, they adhere to the epithelial cells of the tubules and collecting ducts. The host mounts an inflammatory response: neutrophils are recruited, causing localized pyuria (pus in the urine), and the infected tissue becomes edematous and inflamed. In uncomplicated cases, this response is contained within the kidney. In severe cases — particularly with obstruction, immunosuppression, or virulent organisms — bacteria enter the bloodstream (bacteremia), triggering the systemic inflammatory cascade of sepsis.

Why bacteria reach the kidney:

E. coli accounts for approximately 80% of community-acquired pyelonephritis. Other organisms include Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa (more common in hospital-acquired cases), Enterococcus faecalis, and Staphylococcus saprophyticus (common in young sexually active women). In diabetic or immunocompromised patients, Candida spp. must also be considered.

Signs and symptoms

The classic triad of acute pyelonephritis is fever and chills, flank pain, and lower urinary tract symptoms (dysuria, urinary frequency, urgency). However, not all three components need to be present to make the diagnosis, and severity varies widely.

Classic presentation:

• Fever (typically ≥38°C / 100.4°F) with rigors — the fever of pyelonephritis tends to be higher and more sustained than in lower UTI
• Flank pain — unilateral or bilateral, ranging from dull ache to severe pain; located at the costovertebral angle (the junction of the lower rib cage and lumbar spine)
• Costovertebral angle (CVA) tenderness — pain elicited by firm percussion at the CVA with the patient sitting or lying prone; positive CVA tenderness is the hallmark physical exam finding
• Dysuria, urgency, frequency — indicating concurrent or preceding lower UTI
• Nausea and vomiting — common; may lead to dehydration requiring IV fluid resuscitation
• Malaise, myalgia, headache — systemic inflammatory symptoms

Acute vs. chronic presentation:

In elderly patients: Classic symptoms may be absent. Altered mental status, falls, generalized weakness, anorexia, or new incontinence may be the only presenting features. A high index of suspicion is required — always consider urinary source in elderly patients with unexplained fever or new confusion.

In pregnant patients: More common (up to 2% of all pregnancies), more likely to require hospitalization, and more likely to progress to preterm labor or sepsis. Pyelonephritis in pregnancy is always treated with hospitalization and IV antibiotics.

Diagnostic findings

Diagnosis is based on clinical presentation supported by urine analysis, urine culture, and laboratory findings. Imaging is not required in straightforward cases but should be obtained when symptoms are severe, the patient does not improve within 48–72 hours, or complications are suspected.

Urinalysis findings

WBC casts are the key differentiator: their presence on urinalysis confirms renal parenchymal involvement rather than bladder-only infection. Reference the full lab values cheat sheet for normal urinalysis parameters.

Blood and urine cultures

• Urine culture with sensitivity is essential — it confirms the organism and guides antibiotic selection. Collect before starting antibiotics whenever clinically possible.
• Blood cultures (two sets from two different sites) should be obtained in all hospitalized patients with suspected pyelonephritis. Bacteremia is present in approximately 25–30% of hospitalized cases. Positive blood cultures elevate the diagnosis to urosepsis and mandate IV antibiotics.

Complete blood count and metabolic panel

Imaging

CT abdomen/pelvis (with or without contrast) is the imaging study of choice when complications are suspected. It identifies renal abscess, emphysematous pyelonephritis, obstructive cause, and extent of infection. Indications: failure to improve at 48–72 hours, suspected abscess, urosepsis, or unusual presentation.

Renal ultrasound is appropriate when CT is not feasible (pregnancy, contrast allergy, radiation concern). Ultrasound can identify hydronephrosis (obstruction), abscess, and gross structural changes but is less sensitive than CT for subtle findings.

Nursing assessment

Admission assessment priorities

A systematic admission assessment should establish baseline clinical status and identify early warning signs of deterioration toward urosepsis.

Vital signs: Obtain a full set immediately. Fever ≥38°C confirms infection; tachycardia (HR >90) and hypotension (SBP <100) may indicate early sepsis. Track vital sign trends — a worsening trend over 1–2 hours requires escalation. Reference vital signs by age for normal parameters.

CVA tenderness: With the patient sitting upright, place one hand over the CVA (lower back at the junction of the 12th rib and lumbar spine) and firmly strike it with the other fist. Tenderness on percussion confirms upper tract involvement. Assess bilaterally — bilateral tenderness indicates bilateral kidney infection.

Urinary symptoms: Ask specifically about dysuria, frequency, urgency, hematuria, and changes in urine appearance. Document duration of symptoms — when did lower UTI symptoms begin? Symptoms preceding current presentation suggest ascending infection.

Hydration and volume status: Pyelonephritis combined with nausea and vomiting frequently causes dehydration. Assess skin turgor, mucous membranes, and orthostatic vital signs. Check the most recent urine output — oliguria (output <0.5 mL/kg/hr) in the context of pyelonephritis suggests AKI, obstruction, or early sepsis.

Mental status: Any change from baseline — confusion, lethargy, agitation — in the context of suspected pyelonephritis is a red flag for urosepsis until proven otherwise. Altered mental status is one of the three qSOFA criteria (see Urosepsis section below).

Pain assessment: Document location, character, severity (0–10), and radiation. Pyelonephritis pain is typically constant rather than colicky (which suggests an obstructing stone). Severe unrelenting pain in the presence of fever warrants imaging to rule out obstruction or abscess.

Ongoing monitoring: Vital signs every 4 hours (or more frequently if deteriorating), strict intake and output, daily weights, reassessment of CVA tenderness with treatment response, and trending of laboratory values.

Nursing interventions

Intervention summary

Antibiotics

Antibiotic selection depends on severity of illness, local resistance patterns, and culture results. Empiric therapy is started immediately — do not wait for culture results in a symptomatic patient.

Outpatient (uncomplicated, mild-moderate):

• Fluoroquinolone (ciprofloxacin, levofloxacin) for 7 days — first-line if community resistance ≤10%
• Trimethoprim-sulfamethoxazole (TMP-SMX) for 14 days — if local resistance allows
• Oral cephalosporins (cefpodoxime, cefadroxil) for 10–14 days — for patients unable to take fluoroquinolones or TMP-SMX

Inpatient (severe, sepsis, pregnancy, immunocompromised):

• Ceftriaxone IV — preferred initial choice for hospitalized patients without prior ESBL history
• Piperacillin-tazobactam IV — broader coverage; used when resistant organisms suspected or prior healthcare exposure
• Fluoroquinolones IV — acceptable alternative in non-pregnant adults
• Carbapenems (meropenem, ertapenem) — reserved for ESBL-producing organisms or critically ill patients
• Step-down to oral therapy once the patient is afebrile and tolerating oral intake — typically at 24–48 hours if blood cultures are negative or organism is susceptible to oral agents

Pregnant patients: Ceftriaxone IV is the preferred agent. Fluoroquinolones, TMP-SMX, and nitrofurantoin are avoided in pregnancy.

Fluid management

Most hospitalized patients with pyelonephritis are volume-depleted from fever and vomiting. Isotonic crystalloids (normal saline or lactated Ringer’s) are the standard initial resuscitation fluid.

• Goal urine output: 0.5–1 mL/kg/hr
• Monitor for adequate response: improved vital signs, improved urine output, resolution of dry mucous membranes
• In urosepsis: 30 mL/kg IV crystalloid bolus within the first hour per Surviving Sepsis Campaign guidelines
• Avoid excessive fluid administration in patients with known heart failure or AKI — balance resuscitation against fluid overload risk

Pain and fever management

• Acetaminophen is the safest analgesic for pyelonephritis — effective for both pain and fever without renal concerns
• NSAIDs (ibuprofen, ketorolac) may be used for pain if renal function is normal but should be withheld if creatinine is elevated, oliguria is present, or the patient is volume-depleted — NSAIDs reduce prostaglandin-mediated renal perfusion and can precipitate AKI
• Opioid analgesics are reserved for severe pain not controlled with first-line agents
• Warm compresses or heating pads to the flank provide adjunctive comfort
• Antipyretics reduce discomfort from fever and decrease insensible fluid losses

Patient education

• Complete the full antibiotic course — stopping early when symptoms improve allows resistant organisms to persist and causes recurrent infection
• Hydrate well — 2–3 liters of fluid daily unless restricted; adequate urine output flushes bacteria from the urinary tract
• Void frequently — do not hold urine for long periods; stasis promotes bacterial growth
• Wipe front to back (for women) — reduces fecal bacterial contamination of the urethra
• Return immediately if fever returns, pain worsens, or urine output decreases — these signs may indicate treatment failure or complication
• Follow-up urine culture at 1–2 weeks post-treatment confirms eradication — this is especially important in pregnant patients
• For patients with recurrent episodes: discuss risk factors, preventive strategies, and whether prophylactic antibiotics are indicated

Urosepsis

Urosepsis is sepsis originating from the urogenital tract. It is the most feared complication of pyelonephritis, carrying a mortality rate of 30–40%. When pyelonephritis is inadequately treated or occurs in the context of obstruction, immunosuppression, or a virulent organism, the local renal infection overwhelms systemic defenses — bacteria and their endotoxins enter the bloodstream, triggering the dysregulated inflammatory response of sepsis.

When to suspect urosepsis

Use the qSOFA (quick SOFA) screening tool at the bedside. A score of ≥2 in a patient with suspected infection indicates high risk for sepsis and poor outcomes:

qSOFA ≥2 in a patient with pyelonephritis = activate sepsis protocol immediately.

Additional warning signs beyond qSOFA:

• Temperature >38.3°C or <36°C (hypothermia in sepsis is an ominous sign)
• Heart rate >90 bpm
• Lactate ≥2 mmol/L (tissue hypoperfusion marker)
• Urine output <0.5 mL/kg/hr for ≥2 consecutive hours
• New confusion, agitation, or somnolence

Escalation protocol

When urosepsis is suspected:

1. Notify the provider immediately — state vitals, mental status, and urosepsis concern using SBAR
2. Obtain blood cultures × 2 (before antibiotics if possible — do not delay antibiotics >1 hour to obtain cultures)
3. Initiate broad-spectrum IV antibiotics within 1 hour — each hour of antibiotic delay decreases survival by approximately 8%
4. IV fluid resuscitation — 30 mL/kg isotonic crystalloid bolus
5. Measure serum lactate — elevated lactate (≥2 mmol/L) confirms tissue hypoperfusion
6. Continuous vital sign monitoring — consider ICU/step-down transfer
7. Vasopressors (norepinephrine, first-line) if MAP cannot be maintained ≥65 mmHg despite fluid resuscitation
8. Urgent imaging (CT abdomen/pelvis) to identify obstructing cause — obstructed infected kidney requires emergent urologic decompression (ureteral stent or percutaneous nephrostomy)

See the full sepsis nursing reference for complete sepsis bundle management.

The critical teaching point: pyelonephritis + obstruction is a urologic emergency. Infected urine trapped above an obstruction (pyonephrosis) cannot be cleared by antibiotics alone — the obstruction must be relieved by urology. If a patient with pyelonephritis and fever does not improve within 48–72 hours of appropriate antibiotics, suspect obstruction and order imaging.

Complications

Urosepsis and septic shock

As described above — the most life-threatening complication. Mortality 30–40%. Early antibiotic initiation and sepsis protocol activation are the keys to survival.

Renal abscess and perinephric abscess

A collection of pus within the renal parenchyma (intrarenal abscess) or in the perirenal fat surrounding the kidney (perinephric abscess). Suspect if the patient fails to defervesce after 48–72 hours of appropriate antibiotics. Requires CT confirmation and usually drainage (percutaneous or surgical) in addition to prolonged antibiotics.

Emphysematous pyelonephritis

A rare but life-threatening necrotizing infection in which gas-forming bacteria (usually E. coli) produce gas within the renal parenchyma. Occurs almost exclusively in diabetic patients. Mortality approaches 38% even with aggressive management. Requires emergent nephrectomy or percutaneous drainage.

Chronic pyelonephritis and renal scarring

Recurrent or poorly treated episodes of pyelonephritis cause progressive cortical scarring. The affected kidney shrinks, cortical tissue is replaced by fibrous scar, and tubular function deteriorates. Over years, this leads to chronic kidney disease and hypertension (from RAAS activation in the scarred kidney). Children with vesicoureteral reflux and recurrent pyelonephritis are at particular risk.

Acute kidney injury

Severe pyelonephritis — especially with obstruction, septic emboli, or hypoperfusion — can cause AKI through multiple mechanisms: tubular ischemia from sepsis-related hypoperfusion, direct bacterial tubular injury, and post-obstructive damage. Monitor creatinine and urine output closely throughout admission.

NCLEX-style practice questions

Question 1

A nurse is assessing a patient admitted with suspected pyelonephritis. Which physical examination technique is most specific for confirming upper urinary tract involvement?

A. Palpation of the suprapubic area for bladder distension B. Deep palpation of the left lower quadrant for rebound tenderness C. Percussion of the costovertebral angle for tenderness D. Auscultation of the renal arteries for bruits

Answer: C

Rationale: Costovertebral angle (CVA) tenderness — elicited by firm percussion at the junction of the 12th rib and lumbar spine — is the hallmark physical examination finding for upper urinary tract involvement. Positive CVA tenderness distinguishes pyelonephritis (upper tract) from cystitis (lower tract). Suprapubic tenderness indicates bladder involvement only. Rebound tenderness suggests peritoneal pathology. Renal artery bruits assess for renovascular disease.

Question 2

A patient with pyelonephritis has the following vital signs: temperature 39.1°C, HR 112 bpm, RR 24 breaths/min, BP 94/58 mmHg, and new confusion. What is the nurse’s priority action?

A. Obtain a urine specimen for culture and sensitivity B. Apply a cool compress to the forehead for fever management C. Activate the sepsis protocol and notify the provider immediately D. Administer the scheduled oral antibiotic dose

Answer: C

Rationale: This patient meets qSOFA criteria for sepsis: altered mental status (+1), RR ≥22 (+1), and SBP ≤100 (+1) — score of 3/3. In the context of a known infection source (pyelonephritis), this presentation is urosepsis until proven otherwise. The nurse’s priority is to activate the sepsis protocol and notify the provider immediately. Blood cultures should be drawn before antibiotics if possible, but antibiotic initiation must not be delayed beyond 1 hour — every hour of delay reduces survival by approximately 8%. Applying a cool compress is a comfort measure that does not address the life-threatening emergency.

Question 3

A nurse is preparing to administer the first dose of ciprofloxacin to a patient with pyelonephritis. Which action is most important before administration?

A. Ensure the patient has taken a full glass of water B. Confirm that blood and urine cultures have been collected C. Verify that the patient has no penicillin allergy D. Check the patient’s most recent serum potassium level

Answer: B

Rationale: Blood and urine cultures must be collected before the first antibiotic dose whenever possible. Once antibiotics are administered, organisms begin to die and culture yield drops significantly — a sterilized culture provides no information about the causative organism or its antibiotic sensitivities. This prevents targeted de-escalation and appropriate antibiotic stewardship. Ciprofloxacin is a fluoroquinolone (not a beta-lactam), so penicillin allergy is not relevant. While hydration is important, it is not the priority action before antibiotic administration. Potassium monitoring is part of ongoing care, not a pre-administration check specific to ciprofloxacin.

Question 4

A 28-year-old pregnant patient at 22 weeks gestation is admitted with acute pyelonephritis, fever, and vomiting. Which antibiotic would the nurse expect to be ordered?

A. Ciprofloxacin IV B. Trimethoprim-sulfamethoxazole (TMP-SMX) C. Ceftriaxone IV D. Nitrofurantoin

Answer: C

Rationale: Ceftriaxone IV is the preferred antibiotic for pyelonephritis in pregnancy. Fluoroquinolones (option A) are avoided in pregnancy due to risk of fetal cartilage damage. TMP-SMX (option B) is avoided particularly in the first trimester (folate antagonism) and near term (neonatal jaundice risk). Nitrofurantoin (option D) is appropriate for lower UTI but is not indicated for pyelonephritis (upper tract infection) and is contraindicated at term. Pyelonephritis in pregnancy always warrants hospitalization and IV antibiotic therapy regardless of disease severity.

Question 5

A patient with pyelonephritis has been receiving IV ceftriaxone for 36 hours. She is now afebrile, her HR is 82 bpm, and she is tolerating oral fluids. Urine culture results show E. coli sensitive to ciprofloxacin. What would the nurse anticipate the provider ordering?

A. Continue IV ceftriaxone for a total of 14 days B. Add metronidazole IV for anaerobic coverage C. Transition to oral ciprofloxacin and prepare for discharge D. Repeat blood cultures before considering any change to therapy

Answer: C

Rationale: Step-down from IV to oral therapy is appropriate when the patient is clinically improving: afebrile, hemodynamically stable, and tolerating oral intake. The culture and sensitivity result confirms E. coli sensitivity to ciprofloxacin, making oral fluoroquinolone therapy appropriate. The standard total treatment duration for uncomplicated pyelonephritis with fluoroquinolones is 7 days (counting both IV and oral portions). Continuing IV antibiotics for 14 days is unnecessarily prolonged once oral step-down criteria are met. Adding metronidazole is not indicated — anaerobic coverage is not required for standard pyelonephritis caused by gram-negative enteric organisms.

Question 6

A nurse is educating a patient being discharged after hospitalization for pyelonephritis. Which instruction is most important to include?

A. “You can stop the antibiotic once your fever is gone for 24 hours.” B. “Reduce your fluid intake to prevent urinary urgency.” C. “Complete the full antibiotic course and follow up for a repeat urine culture in 1–2 weeks.” D. “Avoid all NSAIDs permanently because of the kidney damage from your infection.”

Answer: C

Rationale: Completing the full antibiotic course is essential — stopping early when symptoms resolve is one of the most common causes of recurrent pyelonephritis and antibiotic resistance. A follow-up urine culture at 1–2 weeks confirms microbiological eradication. Reducing fluid intake (option B) is incorrect — adequate hydration is protective and helps clear bacteria from the urinary tract; the goal is 2–3 liters daily. Option A is dangerous — symptom resolution does not mean bacteriological cure. Option D is overly restrictive — NSAIDs can be used once renal function returns to baseline, but should be avoided during the acute infection if AKI is suspected.

Related pages

• Hydronephrosis nursing — pyelonephritis as a complication of obstructed hydronephrosis
• AKI nursing reference — acute kidney injury as a complication of severe pyelonephritis
• Sepsis nursing reference — full sepsis bundle management for urosepsis
• CKD and ESRD nursing — chronic kidney disease from recurrent pyelonephritis
• Nursing lab values cheat sheet — urinalysis and serum values reference
• Head-to-toe assessment — systematic assessment framework

This reference was written for nursing students preparing for clinical practice and NCLEX. Clinical decisions must always be made in conjunction with current institutional protocols, provider orders, and individualized patient assessment.

Author: Lindsay Smith, AGPCNP

Sources: Acute Pyelonephritis — StatPearls, NCBI Bookshelf (NBK519537); Urosepsis — StatPearls, NCBI Bookshelf (NBK482344); Urosepsis — Etiology, Diagnosis, and Treatment, PMC4711296; qSOFA Score for Sepsis, MDCalc; Surviving Sepsis Campaign International Guidelines.